Fundraising Fox

Strategikon Pharma

San Francisco, US · Delaware corporation · 5 known investors

strategikonpharma.com ↗

Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools. It serves biopharmaceutical companies of all sizes and Clinical Research Organizations (CROs) involved in clinical trial outsourcing.

AI & Machine LearningBiotechHealthtechSaaSin /clinical-maestro

Founders & leadership

AC
Anca CopaescuFounder
PC
Paulo CarvalhoExecutive Officer
MW
Mark WeinsteinExecutive Officer, Director
MD
Mark Di IanniExecutive Officer, Director, Promoter
RH
Rob HessDirector
VL
Vincent LepreuxDirector
NL
Nathanael LentzDirector
DA
Debra ApruzzeseDirector
CC
Chris CodeanneDirector

Investors · 5

Band of AngelsSilicon Valley
Debiopharm Innovation FundLausanne · $1M – $5M
HearstLabNew York · $500K – $1M
Golden SeedsreportedFlushing · $250K – $2M
Osage Venture PartnersreportedBala Cynwyd · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$2.3MraisedNov 2025 · 15 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rob HessDirector
  • Anca CopaescuExecutive Officer, Director
  • Debra ApruzzeseDirector
  • Chris CodeanneDirector
  • Paulo CarvalhoExecutive Officer
  • Vincent LepreuxDirector
  • Mark WeinsteinExecutive Officer, Director
  • Nathanael LentzDirector
Offering amount
$3M
Amount sold
$2.3M
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedApr 2018 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Anca CopaescuExecutive Officer, Director, Promoter
  • Paulo CarvalhoExecutive Officer, Promoter
  • Mark Di IanniExecutive Officer, Director, Promoter
Incorporated
Corporation, Delaware, 2017
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$1MofferedNov 2017 · Business Services
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark Di IanniExecutive Officer, Director, Promoter
  • Paulo CarvalhoExecutive Officer, Director, Promoter
  • Anca CopaescuExecutive Officer, Director, Promoter
Offering amount
$1M
Minimum investment
$20K
Proceeds to insiders
$150K
Incorporated
Corporation, Delaware, 2017
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.